Apparently we made the front page of the NYT print edition yesterday.
"Drug Company To Compensate Genetic Donors", while true and important, is the least of what we're doing. But that's the kind of headline that grabs eyeballs, I guess. Thankfully the actual article was actually pretty great.
https://www.linkedin.com/posts/variantbio_hot-off-the-printed-press-this-morning-activity-7283932310654124032-WNxm/
=> More informations about this toot | View the thread | More toots from hackerfriendly@mas.to
text/geminiThis content has been proxied by September (3851b).